SEI Investments’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-34,640
| Closed | -$3.23M | – | 2701 |
|
|
2021
Q4 | $3.23M | Sell |
34,640
-37,324
| -52% | -$2.46M | 0.01% | 1352 |
|
|
2021
Q3 | $4.28M | Sell |
71,964
-1,166
| -2% | -$68.9K | 0.01% | 1163 |
|
|
2021
Q2 | $4.98M | Buy |
73,130
+8,393
| +13% | +$547K | 0.01% | 1076 |
|
|
2021
Q1 | $4.55M | Sell |
64,737
-18,269
| -22% | -$1.41M | 0.01% | 1071 |
|
|
2020
Q4 | $6.38M | Buy |
83,006
+1,197
| +1% | +$89.7K | 0.02% | 856 |
|
|
2020
Q3 | $6.12M | Sell |
81,809
-10,637
| -12% | -$709K | 0.02% | 775 |
|
|
2020
Q2 | $5.78M | Buy |
+92,446
| New | +$5.09M | 0.02% | 790 |
|
|
2019
Q3 | – | Sell |
-12,874
| Closed | -$722K | – | 2447 |
|
|
2019
Q2 | $722K | Buy |
+12,874
| New | +$665K | ﹤0.01% | 1714 |
|
|
2018
Q3 | – | Sell |
-19
| Closed | -$1K | – | 3631 |
|
|
2018
Q2 | $1K | Buy |
+19
| New | +$817 | ﹤0.01% | 3551 |
|
|
2015
Q4 | – | Sell |
-12,965
| Closed | -$248K | – | 2747 |
|
|
2015
Q3 | $248K | Buy |
+12,965
| New | +$440K | ﹤0.01% | 1553 |
|
SEI Investments's ARNA Position: Q1 2022 in Review
SEI Investments sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 34,640 shares — an estimated $3.23M sold.
SEI Investments first reported a position in ARNA in Q3 2015 and held it in 10 quarters. The position peaked at $6.38M in Q4 2020. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- SEI Investments reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- SEI Investments sold 34,640 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $3.23M.
- SEI Investments first reported a position in Arena Pharmaceuticals Inc in Q3 2015 and held it in 10 quarters.
- SEI Investments's Arena Pharmaceuticals Inc position peaked at $6.38M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on SEI Investments's 13F filing for Q1 2022, filed 13 May 2022.